Recordati

EUSA Pharma, founded in March 2006 and headquartered in the UK, is a profitable specialty pharmaceutical company that operates globally with a focus on oncology and other critical diseases. The company markets a portfolio of five approved specialty hospital products, including Caphosol®, Xenazine®, Collatamp®, Custodiol®, and Fomepizole®, along with several named-patient products. EUSA Pharma is dedicated to addressing rare diseases and conditions such as oral mucositis, a common side effect of cancer treatments. The company has submitted a Marketing Authorization Application for FOTIVDA (tivozanib HCL) as a first-line therapy for renal cell carcinoma. With plans to expand its portfolio through acquisitions and in-licensing, EUSA Pharma's operations extend across Europe and the USA, supported by a network of commercial partners in Europe, the Middle East, Asia, and Latin America, making its products available in approximately 40 countries worldwide. The company is led by an experienced management team with a strong track record in the specialty pharmaceutical sector.

Pro Farma is a company engaged in the sourcing and distribution of medicinal products, including both prescription and over-the-counter drugs, primarily within Switzerland. It specializes in selected therapeutic areas and also offers a variety of services for pharmaceutical companies, supporting their operations in Switzerland and internationally. Through its focused approach, Pro Farma aims to enhance the availability of essential pharmaceutical products and foster collaborations with industry partners.

Italchimici Spa, along with its subsidiaries, produces and supplies raw materials.

Casen Fleet Laboratories is a Madrid-based manufacturer of pharmaceutical products, focusing primarily on gastroenterology and women's health. Established in 1985, the company operates a facility in Zaragoza that spans 23,000 square meters, which has undergone significant expansions and renovations to enhance its production capabilities. The company is dedicated to developing new products, conducting clinical research, and marketing these products within its specialized areas. With a range of specialist-endorsed offerings, Casen Fleet Laboratories aims to address specific health needs while ensuring high standards of quality and innovation in its pharmaceutical solutions.

Opalia Pharma S.A. is a pharmaceutical manufacturer based in Ariana, Tunisia, specializing in the production and marketing of generic medicinal products. Founded in 1988, the company offers a diverse range of products targeting dermatology, gastrointestinal, and respiratory diseases, primarily in liquid and semi-solid forms. In addition to its manufacturing capabilities, Opalia Pharma provides various services, including development, regulatory support, and pharmaceutical release, alongside galenical and analytical development services. Its expertise encompasses the production of creams, ointments, gels, suppositories, and pessaries, catering to both external and internal medical needs. As of 2014, Opalia Pharma operates as a subsidiary of Recordati Industria Chimica e Farmaceutica S.p.A.

Farma-Projekt Sp. z o.o. produces various dietary supplements. Its products include Gastro Up, a dietary supplement for the functioning of digestive tract; Inhepax.

Orphan Europe SARL is a pharmaceutical company focused on the development of orphan medicinal products aimed at treating rare metabolic disorders. The company offers a portfolio that includes Cystadane, Cystagon, Normosang, and Wilzin, providing essential therapies for patients with these specific health conditions. By specializing in orphan drugs, Orphan Europe seeks to improve access to necessary treatments for individuals affected by rare diseases, thereby fulfilling a critical need in the healthcare market.